| Breast cancer and associated factors: a review MR Ataollahi, J Sharifi, MR Paknahad, A Paknahad Journal of medicine and life 8 (Spec Iss 4), 6, 2015 | 221 | 2015 |
| The role of magnesium in different inflammatory diseases A Shahi, S Aslani, MR Ataollahi, M Mahmoudi Inflammopharmacology 27, 649-661, 2019 | 84 | 2019 |
| Increased serum levels of IL-17A and IL-23 are associated with decreased vitamin D3 and increased pain in osteoarthritis A Askari, MM Naghizadeh, R Homayounfar, A Shahi, MH Afsarian, ... PloS one 11 (11), e0164757, 2016 | 71 | 2016 |
| An elevated pro-inflammatory cytokines profile in Behcet’s disease: a multiplex analysis N Gholijani, MR Ataollahi, A Samiei, E Aflaki, S Shenavandeh, ... Immunology letters 186, 46-51, 2017 | 68 | 2017 |
| Chitosan/gelatin hydrogel and endometrial stem cells with subsequent atorvastatin injection impact in regenerating spinal cord tissue ME Astaneh, A Goodarzi, M Khanmohammadi, A Shokati, ... Journal of Drug Delivery Science and Technology 58, 101831, 2020 | 33 | 2020 |
| In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran T Shokohi, H Badali, N Amirrajab, MR Ataollahi, SA Kouhpayeh, ... Current Medical Mycology 2 (2), 34, 2016 | 27 | 2016 |
| Decreased serum levels of IL-27and IL-35 in patients with Graves disease MH Saeed, K Kurosh, A Zahra, DM Hossein, R Davood, MR Ataollahi Archives of endocrinology and metabolism 64, 521-527, 2020 | 16 | 2020 |
| In vitro activity of four triazole antifungal drugs against clinically common and uncommon yeast species N Aslani, T Shokohi, MR Ataollahi, S Ansari, Y Gholampour, AK Jeihooni, ... Current Medical Mycology 5 (4), 14, 2019 | 9 | 2019 |
| Evaluation of ARG protein expression in mature B cell lymphomas compared to non-neoplastic reactive lymph node Z Kabiri, M Salehi, F Mokarian, MR Mohajeri, F Mahmoodi, K Keyhanian, ... Cellular immunology 259 (2), 111-116, 2009 | 9 | 2009 |
| Effect of PCL nanofiber mats coated with chitosan microcapsules containing cinnamon essential oil for wound healing M Osanloo, F Noori, A Tavassoli, MR Ataollahi, A Davoodi, ... BMC Complementary Medicine and Therapies 23 (1), 84, 2023 | 8 | 2023 |
| Molecular identification of clinically common and uncommon yeast species T Shokohi, N Moradi, L Badram, H Badali, MR Ataollahi, MH Afsarian Jundishapur Journal of Microbiology 11 (10), 2018 | 8 | 2018 |
| Association between MDR1 C3435T gene polymorphism and acute lymphoblastic leukemia (ALL) in Iranian population B Miladpour, J Behravan, SA NEJAT, A Banihashem, H Smaili, ... IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ) 12 (3), 277-281, 2010 | 7 | 2010 |
| The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes P Fazeli, AG Talepoor, Z Faghih, N Gholijani, MR Ataollahi, ... Immunity, Inflammation and Disease 10 (10), e715, 2022 | 5 | 2022 |
| Anti-cardiolipin and anti-neutrophil cytoplasmic antibodies in Iranian patients with Behcet's disease MR Ataollahi, E Aflaki, MA Nazarinia, S Shenavandeh, Z Habibagahi, ... Iranian Journal of Immunology 9 (4), 241-247, 2012 | 5 | 2012 |
| Comparison of the antibody responses following vaccination with AstraZeneca and Sinopharm E Anvari, AG Talepoor, M Eshkevar Vakili, N Karimi, MR Ataollahi, ... Iranian Journal of Immunology 19 (3), 321-329, 2022 | 4 | 2022 |
| Evaluation of anticoagulant and inflammatory effects of Tanacetum parthenium (L.) in a randomized controlled clinical trial M Ataollahi, E Akrami, M Kalani, M Zarei, MR Chijan, ... Journal of Herbal Medicine 36, 100613, 2022 | 3 | 2022 |
| Absence of autoantibodies against oral and vascular-related cell lines in the sera of patients with Behcet's disease. M Ataollahi, B Gharesi-Fard, E Aflaki Clinical laboratory 59 (11-12), 1271-1276, 2013 | 2 | 2013 |
| Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma M Ataollahi, M Salehi, I Doostan, Z Kabiri, M Mohajeri, F Mahmoodi, ... Iranian Journal of Immunology 5 (2), 124-130, 2008 | 2 | 2008 |
| Study of ARG (ABL Related Gene-ABL2) Protein, a Tyrosine Kinase Protein, in Burkitt's Lymphoma M SALEHI, Z Kabiri, F Mokarian, I DOUSTAN, EMR ATA, DMR NOURI JOURNAL OF SCIENCES ISLAMIC REPUBLIC OF IRAN 18 (3), 215-220, 2007 | 2 | 2007 |
| Targeting T cell metabolism as a novel approach for treatment of MS: with a focus on PFKFB3 inhibitors ME Vakili, FN Shah Mohammadi, MR Ataollahi, K Shams, KK Eklund, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023 | 1 | 2023 |
